A number of executives at the British drug maker GlaxoSmithKline have admitted to criminal charges of bribery and tax law violations, according to China's Public Security Bureau.
The ministry said that a number of senior executives were suspected of bribing government officials, medical associations, hospitals and doctors to boost sales and prices.
It also alleged that the company had violated tax laws by using fake receipts.The names or number of executives under investigation has yet to be revealed.
The company has denied the allegations and said it would investigate.
The British drugmaker, which is one of the world's largest pharmaceutical companies, was already under investigation in China for alleged economic crimes and price-fixing, with Chinese authorities visiting the company's sites in Beijing, Shanghai and Changsha.
